 | Up a level |
Kurch, L; Hasenclever, D; Kluge, R; Georgi, T; Tchavdarova, L; Golombeck, M; Sabri, O; Eggert, A; Brenner, W; Sykora, K W; Bengel, F M; Rossig, C; Körholz, D; Schäfers, M; Feuchtinger, T; Bartenstein, P; Ammann, Roland; Krause, T; Urban, C; Aigner, R; ... (2019). Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial. Pediatric blood & cancer, 66(3), e27539. Wiley-Liss 10.1002/pbc.27539
Leich, E; Hoster, E; Wartenberg, Martin; Unterhalt, M; Siebert, R; Koch, K; Klapper, W; Engelhard, M; Puppe, B; Horn, H; Staiger, A M; Stuhlmann-Laeisz, C; Bernd, H W; Feller, A C; Hummel, M; Lenze, D; Stein, H; Hartmann, S; Hansmann, M L; Möller, P; ... (2016). Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus. Leukemia, 30(4), pp. 854-860. Nature Publishing Group 10.1038/leu.2015.330
Horn, H; Ziepert, M; Wartenberg, Martin; Staiger, A M; Barth, T F E; Bernd, H-W; Feller, A C; Klapper, W; Stuhlmann-Laeisz, C; Hummel, M; Stein, H; Lenze, D; Hartmann, S; Hansmann, M-L; Möller, P; Cogliatti, S; Pfreundschuh, M; Trümper, L; Loeffler, M; Glass, B; ... (2015). Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma. Leukemia, 29(7), pp. 1564-1570. Nature Publishing Group 10.1038/leu.2015.43
